Annual ROE
-50.90%
+12.80%+20.09%
December 31, 2023
Summary
- As of February 12, 2025, NVNO annual return on equity is -50.90%, with the most recent change of +12.80% (+20.09%) on December 31, 2023.
- During the last 3 years, NVNO annual ROE has risen by +77.81% (+60.45%).
- NVNO annual ROE is now -138.93% below its all-time high of 130.74%, reached on December 31, 2017.
Performance
NVNO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-48.73%
+5.51%+10.16%
September 30, 2024
Summary
- As of February 12, 2025, NVNO quarterly return on equity is -48.73%, with the most recent change of +5.51% (+10.16%) on September 30, 2024.
- Over the past year, NVNO quarterly ROE has increased by +21.44% (+30.55%).
- NVNO quarterly ROE is now -105.19% below its all-time high of 939.81%, reached on December 31, 2018.
Performance
NVNO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NVNO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.1% | +30.6% |
| 3 y3 years | +60.5% | +23.3% |
| 5 y5 years | +92.0% | +23.3% |
NVNO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.5% | +20.1% | -44.7% | +35.9% |
| 5 y | 5-year | -67.5% | +89.9% | -52.4% | +92.2% |
| alltime | all time | -138.9% | +92.0% | -105.2% | +92.2% |
EnVVeno Medical ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -48.73%(-10.2%) |
| Jun 2024 | - | -54.24%(-12.8%) |
| Mar 2024 | - | -62.17%(-11.4%) |
| Dec 2023 | -50.90%(-20.1%) | -70.17%(-7.7%) |
| Sep 2023 | - | -75.99%(+9.1%) |
| Jun 2023 | - | -69.68%(+9.7%) |
| Mar 2023 | - | -63.50%(+15.4%) |
| Dec 2022 | -63.70%(+109.7%) | -55.04%(-2.4%) |
| Sep 2022 | - | -56.38%(+24.7%) |
| Jun 2022 | - | -45.20%(+21.2%) |
| Mar 2022 | - | -37.30%(+10.8%) |
| Dec 2021 | -30.38%(-76.4%) | -33.67%(+5.3%) |
| Sep 2021 | - | -31.98%(-33.4%) |
| Jun 2021 | - | -48.03%(-38.3%) |
| Mar 2021 | - | -77.79%(-73.9%) |
| Dec 2020 | -128.71% | -298.36%(-35.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -459.46%(-26.2%) |
| Jun 2020 | - | -622.53%(+88.0%) |
| Mar 2020 | - | -331.13%(+25.8%) |
| Dec 2019 | -503.93%(-21.3%) | -263.15%(+16.8%) |
| Sep 2019 | - | -225.24%(+8.9%) |
| Jun 2019 | - | -206.77%(-31.6%) |
| Mar 2019 | - | -302.39%(-132.2%) |
| Dec 2018 | -640.48%(-589.9%) | 939.81%(+121.3%) |
| Sep 2018 | - | 424.74%(+76.7%) |
| Jun 2018 | - | 240.34%(+91.3%) |
| Mar 2018 | - | 125.63%(+10.1%) |
| Dec 2017 | 130.74%(+62.9%) | 114.15%(+14.9%) |
| Sep 2017 | - | 99.39%(+4.5%) |
| Jun 2017 | - | 95.10%(+6.1%) |
| Mar 2017 | - | 89.60%(+44.5%) |
| Dec 2016 | 80.28%(+79.0%) | 62.02% |
| Dec 2015 | 44.84% | - |
FAQ
- What is enVVeno Medical annual return on equity?
- What is the all time high annual ROE for enVVeno Medical?
- What is enVVeno Medical annual ROE year-on-year change?
- What is enVVeno Medical quarterly return on equity?
- What is the all time high quarterly ROE for enVVeno Medical?
- What is enVVeno Medical quarterly ROE year-on-year change?
What is enVVeno Medical annual return on equity?
The current annual ROE of NVNO is -50.90%
What is the all time high annual ROE for enVVeno Medical?
enVVeno Medical all-time high annual return on equity is 130.74%
What is enVVeno Medical annual ROE year-on-year change?
Over the past year, NVNO annual return on equity has changed by +12.80% (+20.09%)
What is enVVeno Medical quarterly return on equity?
The current quarterly ROE of NVNO is -48.73%
What is the all time high quarterly ROE for enVVeno Medical?
enVVeno Medical all-time high quarterly return on equity is 939.81%
What is enVVeno Medical quarterly ROE year-on-year change?
Over the past year, NVNO quarterly return on equity has changed by +21.44% (+30.55%)